LC-MS Bioanalysis of Peptides and Polypeptides

Handbook of LC-MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations

Volumn , Issue , 2013, Pages 535-549

  Li, Hongyan ^a   James, Christopher A ^a  

^a AMGEN INC   (United States)

Author keywords

Liquid chromatography mass spectrometry (LC MS,LC MS MS); Peptide bioanalysis; Peptide quantification; Peptides; Polypeptides

Indexed keywords

BIOMATERIALS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYPEPTIDES;

BIOANALYSIS; BIOLOGICAL SAMPLE PREPARATION; LC-MS/MS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MASS SPECTROMETRIC DETECTION; PEPTIDE QUANTIFICATION; PHYSICOCHEMICAL CHARACTERISTICS; SEPARATION TECHNIQUES;

PEPTIDES;

EID: 84955506446     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118671276.ch42     Document Type: Chapter

References (45)

1. Berna M, Schmalz C, Duffin K, Mitchell P, Chambers M, Ackermann B. Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: investigation of the impact of collisioninduced dissociation fluctuation on peptide quantitation. Anal Biochem 2006;356:235-243.
2. Berna M, Ott L, Engle S,Watson D, Solter P, Ackermann B. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy. Anal Chem 2008;80:561-566.
3. Chang D, Kolis SJ, Linderholm KH, et al. Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS. J Pharm Biomed Anal 2005;38:487-496.
4. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLCES/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2005;825:134-143.
5. Cutillas PR. Analysis of peptides in biological fluids by LC-MS/MS. Methods Mol Biol 2010;658:311-321.
6. Dalluge JJ. Mass spectrometry: an emerging alternative to traditional methods for measurement of diagnostic proteins, peptides and amino acids. Curr Protein Pept Sci 2002;3:181-190.
7. De Kock SS, Rodgers JP, Swanepoel BC. Growth hormone abuse in the horse: preliminary assessment of a mass spectrometric procedure for IGF-1 identification and quantitation. Rapid Commun Mass Spectrom 2001;15:1191-1197.
8. Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS. Bioanalysis 2011;3:1379-1397.
9. Geng X, Regnier FE. Retention model for proteins in reversed-phase liquid chromatography. J Chromatogr 1984;296:15-30.
10. Hager JW, Le Blanc JC. High-performance liquid chromatography-tandem mass spectrometry with a newquadrupole/linear ion trap instrument. J Chromatogr A 2003;1020:3-9.
11. Halquist MS, Karnes TH. Quantitative liquid chromatography tandem mass spectrometry analysis of macromolecules using signature peptides in biological fluids. Biomed Chromatogr 2010;25:47-58.
12. Ji QC, Rodila R, Gage EM, El-Shourbagy TA. A strategy of plasma protein quantitation by selective reaction monitoring of an intact protein. Anal Chem 2003;75:7008-7014.
13. John H, Walden M, Schafer S, Genz S, Forssmann WG. Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal Bioanal Chem 2004;378:883-897.
14. Johnson RS, Martin SA, Biemann K, Stults JT, Watson JT. Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine. Anal Chem 1987;59:2621-2625.
15. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom 2000;11:942-950.
16. Li WW, Nemirovskiy O, Fountain S, Rodney Mathews W, Szekely-Klepser G. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: a biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Anal Biochem 2007;369: 41-53.
17. Li H, Rose MJ, Tran L, et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009;59:171-180.
18. Li H, Rose MJ, Holder JR, Wright M, Miranda LP, James CA. Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS. J Am Soc Mass Spectrom 2011;22:1660-1667.
19. Lien S, Lowman HB. Therapeutic peptides. Trends Biotechnol 2003;21:556-562.
20. Londry FA, Hager JW. Mass selective axial ion ejection from a linear quadrupole ion trap. J Am Soc Mass Spectrom 2003;14:1130-1147.
21. Mesmin C, Dubois M, Becher F, Fenaille F, Ezan E. Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma. Rapid Commun Mass Spectrom 2010;24:2875-2884.
22. Michalski A, Damoc E, Hauschild JP, et al. Mass spectrometrybased proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics 2011;10:M111.011015.
23. Miranda LP, Holder JR, Shi L, et al. Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor. J Med Chem 2008a;51:7889-7897.
24. Miranda LP, Winters KA, Gegg CV, et al. Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity. J Med Chem 2008b;51:2758-2765.
25. Motoyama A, Venable JD, Ruse CI, Yates JR 3rd. Automated ultrahigh-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples. Anal Chem 2006;78:5109-5118.
26. Motoyama A, Xu T, Ruse CI,Wohlschlegel JA, Yates JR 3rd. Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides. Anal Chem 2007;79:3623-3634.
27. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom 1984;11:601.
28. Sato AK, Viswanathan M, Kent RB, Wood CR. Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 2006;17:638-642.
29. Schwartz JC, Senko MW, Syka JE. A two-dimensional quadrupole ion trap mass spectrometer. J Am Soc Mass Spectrom 2002;13:659-669.
30. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE). J Pharm Biomed Anal 2005;37:359-367.
31. Shipkova P, Drexler DM,Langish R, Smalley J, Salyan ME, Sanders M. Application of ion trap technology to liquid chromatography/mass spectrometry quantitation of large peptides. Rapid Commun Mass Spectrom 2008;22:1359-1366.
32. Shushan B. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom Rev 2010;29:930-944.
33. Song KH, An HM, Kim HJ, Ahn SH, Chung SJ, Shim CK. Simple liquid chromatography-electrospray ionization mass spectrometry method for the routine determination of salmon calcitonin in serum. J Chromatogr B Analyt Technol Biomed Life Sci 2002;775:247-255.
34. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schanzer W. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Anal Chem 2006;78:1897-1903.
35. Van Den Broek I, Sparidans RW, Huitema AD, Schellens JH, Beijnen JH. Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006;837:49-58.
36. Van Den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices: measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007;854:245-259.
37. Van Den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008;872:1-22.
38. Van Den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:590-602.
39. Wilson SF, Li H, Rose MJ, Xiao J, Holder JR, James CA. Development and validation of a method for the determination of a therapeutic peptide with affinity for the human B1 receptor in human plasma using HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:749-757.
40. Wolf R, Hoffmann T, Rosche F, Demuth HU. Simultaneous determination of incretin hormones and their truncated forms from human plasma by immunoprecipitation and liquid chromatography-mass spectrometry. JChromatogrBAnalyt Technol Biomed Life Sci 2004;803:91-99.
41. Wolf R, Rosche F, Hoffmann T, Demuth HU. Immunoprecipitation and liquid chromatographic-mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 from human plasma samples. New sensitive method to analyze physiological concentrations of peptide hormones. J Chromatogr A 2001;926:21-27.
42. Wu ST, Ouyang Z, Olah TV, Jemal M. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection. Rapid Commun Mass Spectrom 2011;25:281-290.
43. Xu Y, Mehl JT, Bakhtiar R, Woolf EJ. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma. Anal Chem 2010;82:6877-6886.
44. Xue YJ, Akinsanya JB, Liu J, Unger SE. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma. Rapid Commun Mass Spectrom 2006;20:2660-2668.
45. Yamaguchi K, Takashima M, Uchimura T, Kobayashi S. Development of a sensitive liquid chromatography-electrospray ionization mass spectrometry method for the measurement of KW-5139 in rat plasma. Biomed Chromatogr 2000;14: 77-81.